Celosia Therapeutics
Developer of neurotherapeutic interventions designed for treatment-resistant neurodegenerative conditions. The company modifies the neuronal microenvironment through targeted molecular approaches, foc...
Valuation
$0
Share Price
N/A
Total Raised
$18.8M
Last Round
N/A